# Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast

> **NCT01249157** · NA · TERMINATED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Positron Emission Mammography (PEM) and Magnetic Resonance Imaging (MRI)

## Key facts

- **NCT ID:** NCT01249157
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2015-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01249157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01249157, "Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01249157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*